Company Monitoring Page for Celldex

latest headlines for company on cafepharma

Antibody-drug conjugate against ALK could selectively treat neuroblastoma
BioCentury
Thu, 03/14/19 - 11:09 pm
Tags:
CHOP, Celldex, neuroblastoma, dinutuximab, antibody-drug conjugate
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
Wed, 09/14/16 - 11:53 pm
Tags:
FDA, clinical trials, Array Biopharma, binimetinib, Mast Therapeutics, Novavax, RSV F vaccine, Threshold Pharmaceuticals, tarloxotinib, Cerulean Pharma, Vertex Pharmaceuticals, Orkambi, Exelixis, cabozantinib, Cobimetinib, Medivation, Xtandi, Celldex
Celldex Rose on Phase 2 Melanoma Data
Market Realist
Wed, 06/8/16 - 05:06 pm
Tags:
Celldex, melanoma, CDX‑1401, CDX-301
Celldex vaccine improves long-term brain cancer survival in study
Yahoo/Reuters
Fri, 11/20/15 - 06:23 pm
Tags:
Celldex, vaccines, brain cancer, glioblastoma multiforme, Rintega
3 Cancer Companies to Watch Closely in 2016
Motley Fool
Tue, 10/20/15 - 10:00 am
Tags:
cancer, Celldex, Medivation, Clovis Oncology, rociletinib, talazoparib, Rintega
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
Fierce Biotech
Sun, 05/31/15 - 11:18 am
Tags:
ASCO, Celldex, glioblastoma multiforme, brain cancer, Rintega
Celldex After CDX-1135 - What's The Outlook?
Seeking Alpha
Mon, 05/26/14 - 08:39 am
Tags:
Celldex, CDX-1135
The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
Yahoo/Zacks.com
Thu, 05/22/14 - 08:36 am
Tags:
Incyte, Celldex, Bristol-Myers Squibb, AstraZeneca, Halozyme
Could Bristol-Myers End Up Acquiring Celldex?
Motley Fool
Thu, 05/15/14 - 05:55 pm
Tags:
Celldex, M&A, Bristol-Myers Squibb
Bristol, Celldex Collaborating on Cancer Immunotherapy Study
TheStreet.com
Wed, 05/14/14 - 09:10 am
Tags:
cancer immunotherapy, Celldex, Bristol-Myers Squibb
3 Growing Immunotherapy Companies: Celldex, Merck, OncoSec
Wall St Cheat Sheet
Mon, 02/10/14 - 11:28 am
Tags:
immunotherapy, Celldex, Merck, OncoSec
Is Celldex Offering a Reason to Be Scared?
Motley Fool
Sat, 12/7/13 - 12:42 pm
Tags:
Celldex
Celldex, ImmunoCellular Fall And Rise On Hype And Hope
Seeking Alpha
Wed, 11/27/13 - 08:31 am
Tags:
ImmunoCellular Therapeutics, Celldex, rindopepimut, glioblastoma, ICT-107
2 Biotech Stocks With Strong Buyout Potential
Wall St Cheat Sheet
Mon, 11/25/13 - 11:41 am
Tags:
Acadia, Celldex
Northwest Biotherapeutics Poses Onyx Like Potential
Seeking Alpha
Mon, 11/18/13 - 09:56 am
Tags:
Northwest Biotherapeutics, Agenus, Celldex, ONYX Pharmaceuticals, ImmunoCellular Therapeutics
Will Dendreon Catch Johnson & Johnson or Fall Behind Celldex?
Motley Fool
Mon, 11/11/13 - 10:17 am
Tags:
Dendreon, JNJ, Celldex
Celldex: A View On The Imminent Release Of Data For The Cancer Vaccine Rindopepimut
Seeking Alpha
Mon, 11/4/13 - 03:16 pm
Tags:
vaccines, glioblastoma, rindopepimut, Celldex
Will Seattle Genetics Stay Ahead of ImmunoGen and Celldex?
Motley Fool
Mon, 11/4/13 - 10:27 am
Tags:
Seattle Genetics, Immunogen, Celldex
3 Promising Biotech Stocks with Upcoming Catalysts
Wall St. Cheat Sheet
Mon, 11/4/13 - 10:08 am
Tags:
Sarepta Therapeutics, eteplirsen, NeoStem, AMR-001, Celldex, CDX-110
6 Charts Explain An Ugly October for Biotech Stocks
TheStreet.com
Mon, 11/4/13 - 09:18 am
Tags:
biotech, Catalyst Pharmaceutical Partners, Acadia, Celldex, Biocryst

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.